News
Videos
Keya Medical presents its CT FFR analysis at SCCT2024: Thank You for Visiting.
Keya Medical showcases its deep-learning-based CT FFR analysis at SCCT2024. Contact us for more information or to schedule a personalized demonstration of our deep-learning-based CT FFR solution.
Join us at SCCT2024
Connect with the Keya Medical team at Booth 114, SCCT2024 Washington, D.C. or book a private meeting.
DEEPVESSEL FFR CT-Recent Peer-Reviewed Publications
Following is a sampling of recent peer-reviewed publications and more studies with DEEPVESSEL FFR CT are in progress.
The Stepwise CCTA + FFRCT + CT-MPI Strategy: A Promising Approach for Evaluating Stenosis with Gray Zone FFRCT Values
2024 study to validate a stepwise strategy using FFRCT for intermediate stenosis on CCTA and CT-MPI for vessels with gray zone FFRCT values.
Keya Medical Joins Bayer’s Calantic AI Solution for Radiology
Keya Medical showcases its AI CT-FFR analysis through Bayer’s Calantic Digital Solutions platform at ECR2024.
CT-FFR: Enhancing Selectivity and Precision in Cardiac Patient Care
Selective use of CT-FFR successfully identified patients who would benefit most from invasive procedures, reducing unnecessary interventions.
Advancements in AI-based CT-FFR Analysis with DEEPVESSEL FFR: A Comprehensive Research Overview
Keya Medical’s AI CT-FFR Analysis: focus on its research and publications journey since DEEPVESSEL FFR FDA-clearance.
Keya Medical at 2024 ECR Annual Congress-Next Generation Radiology.
Take advantage of the opportunity to participate in a personalized one-on-one discussion with Keya Medical and explore a product demonstration.
Keya Medical Presents FDA-cleared CT FFR product at SCCT Global 2024 | Budapest
Visit Keya Medical’s booth at SCCT Global 2024 in Budapest, January 16-19.
Scaling your Cardiovascular CT Service and Implementing CT-FFR
Discover the power of automated CT-FFR integration in enhancing your cardiovascular CT services.
Enhancing Cardiovascular Care: The Story of DEEPVESSEL FFR by Keya Medical
Keya Medical’s DEEPVESSEL FFR offers a non-invasive, accurate, and efficient solution for assessing coronary artery function. The product’s journey from inception to global clearances reflects a commitment to advancing medical technology and improving patient outcomes...
Keya Medical Covers Technology Advancements and AI Integration at SCCT 2023: A Look at Exceptional Collaborations.
In the dynamic landscape of medical innovation, SCCT 2023 served as an exceptional platform for exchanging cutting-edge insights and breakthroughs in cardiovascular technology.
